Cell Counting Market estimated to reach 12.32 billion USD by 2023

The cell counting market is expected to reach USD 12.32 billion by 2023 from an estimated USD 8.84 billion in 2018, at a CAGR of 6.8%.

(EMAILWIRE.COM, August 22, 2018 ) Cell Counting Market : High cost of advanced cell counting systems

Advanced instruments such as flow cytometers, multimode microplate readers, and automated hematology analyzers used for cell counting and other cell analysis applications are highly expensive. The price for a flow cytometer instrument varies from USD 35,000 to USD 100,000. For instance, the price of Merck’s Guava EasyCyte 5 is ~USD 45,000 whereas Becton, Dickinson and Company’s Accuri C6 flow cytometer is priced at ~USD 49,000. The SE500 flow cytometer by Stratedigm costs about USD 68,000.

Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownload.asp?id=157450728

Product recalls of hematology analyzers

In the last few years, the Cell Counting Market has witnessed a large number of recalls of hematology analyzers majorly due to inaccurate results. In June 2017, Beckman Coulter (US) recalled the Coulter Hematology Analyzers—LH 750, LH 500, LH 780, and HmX. These products were recalled after the detection of inaccuracies in terms of flagging or detecting blasts in some blood samples. These recalls not only affect consumer confidence but also hamper the reputation of leading players in the market.

Cell Counting Market OPPORTUNITIES

Growing focus on stem cell research
Financial support from public-private organizations has fostered the stem cell research industry over the past few years. Various research projects/institutes have received grants from public and private organizations for their stem cell-related projects. For instance, BD Biosciences supports the research activities of 10 scientists annually, who pursue innovative ideas in stem cell research by providing reagents worth USD 100,000 to these scientists. Furthermore, the US NIH expenditure on stem cell research increased to around USD 1,646 million in 2017 from USD 1,391 million in 2014. An estimated USD 1,748 is expected to be provided for stem cell research by the NIH in 2018.

Press Release : https://www.marketsandmarkets.com/PressReleases/cell-counting.asp

Emerging economies
Increasing research initiatives, continuous improvement in healthcare infrastructure, growing population, and rising healthcare expenditure in emerging countries such as China, India, Brazil, and Mexico have drawn the attention of market leaders to these regions. Regulatory policies in the Asia Pacific region are more adaptive and business-friendly than other markets, due to less stringent regulations and data requirements. This, along with increasing competition in mature markets, has propelled key players in the cell counting market to focus on emerging markets.

Know More : http://www.prnewswire.co.in/news-releases/cell-counting-market-worth-1232-billion-usd-by-2023-688614181.html

Cell Counting Market CHALLENGES

Inadequate infrastructure for research in emerging countries
The growth of the cell counting market in emerging markets is hindered by a lack of infrastructure facilities. For instance, according to the Directorate of Economics and Statistics, India, out of the 4,168 private laboratories in the state of Kerala (India), only 7% have National Accreditation Board for Testing and Calibration Laboratories (NABL) or ISO certification. This is insufficient to cater to the increasing demand for quality healthcare services from the growing middle-class population as well as the disease rate in India.

Dearth of skilled professionals in clinical laboratories
Conventional cell counting techniques such as hemocytometers are now increasingly being replaced by advanced cell counting techniques such as flow cytometers and spectrophotometers, which are reliable, highly accurate, and provide quicker results. However, instruments such as flow cytometers and multimode readers have relatively complex technologies and require experts with a good knowledge of cell-based assays and software handling.